cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
OV	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	12.49	1.78e-28	0.85	0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
OV	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	12.49	1.78e-28	0.85	0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-12.47	2.15e-28	-0.84	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-12.47	2.15e-28	-0.84	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-12.41	3.45e-28	-0.84	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-12.41	3.45e-28	-0.84	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	12.38	4.27e-28	0.85	0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	12.38	4.27e-28	0.85	0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-12.38	4.57e-28	-0.84	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-12.38	4.57e-28	-0.84	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-12.25	1.27e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-12.25	1.27e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-12.25	1.27e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-12.25	1.27e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-12.25	1.27e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-12.25	1.27e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-12.21	1.74e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-12.21	1.74e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-12.21	1.74e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-12.21	1.74e-27	-0.83	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-12.18	2.19e-27	-0.84	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-12.18	2.19e-27	-0.84	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-11.98	1.04e-26	-0.83	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-11.98	1.04e-26	-0.83	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
OV	cis	rs8005677	0.828	rs2295680	MIMAT0019808	hsa-miR-4707-3p	11.84	3.08e-26	0.61	0.59	Cognitive ability (multi-trait analysis);	chr14:22905226	chr14:22956957~22956978:-
OV	cis	rs8005677	0.798	rs4982713	MIMAT0019808	hsa-miR-4707-3p	-11.63	1.54e-25	-0.62	-0.58	Cognitive ability (multi-trait analysis);	chr14:22934893	chr14:22956957~22956978:-
OV	cis	rs8005677	0.798	rs35615180	MIMAT0019808	hsa-miR-4707-3p	-11.63	1.54e-25	-0.62	-0.58	Cognitive ability (multi-trait analysis);	chr14:22935180	chr14:22956957~22956978:-
OV	cis	rs8005677	0.828	rs12589539	MIMAT0019808	hsa-miR-4707-3p	-11.63	1.57e-25	-0.62	-0.58	Cognitive ability (multi-trait analysis);	chr14:22927471	chr14:22956957~22956978:-
OV	cis	rs8005677	0.798	rs61977741	MIMAT0019808	hsa-miR-4707-3p	-11.53	3.34e-25	-0.61	-0.58	Cognitive ability (multi-trait analysis);	chr14:22931770	chr14:22956957~22956978:-
OV	cis	rs8005677	0.828	rs35085068	MIMAT0019808	hsa-miR-4707-3p	-11.49	4.66e-25	-0.62	-0.58	Cognitive ability (multi-trait analysis);	chr14:22940700	chr14:22956957~22956978:-
OV	cis	rs8005677	0.828	rs4981451	MIMAT0019808	hsa-miR-4707-3p	-11.49	4.66e-25	-0.62	-0.58	Cognitive ability (multi-trait analysis);	chr14:22941072	chr14:22956957~22956978:-
OV	cis	rs8005677	0.798	rs4536383	MIMAT0019808	hsa-miR-4707-3p	-11.49	4.66e-25	-0.62	-0.58	Cognitive ability (multi-trait analysis);	chr14:22941717	chr14:22956957~22956978:-
OV	cis	rs8005677	0.828	rs34584578	MIMAT0019808	hsa-miR-4707-3p	-11.49	4.66e-25	-0.62	-0.58	Cognitive ability (multi-trait analysis);	chr14:22942481	chr14:22956957~22956978:-
OV	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-11.42	7.92e-25	-0.82	-0.57	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-11.42	7.92e-25	-0.82	-0.57	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
OV	cis	rs8005677	0.828	rs8016027	MIMAT0019808	hsa-miR-4707-3p	-11.4	9.16e-25	-0.62	-0.57	Cognitive ability (multi-trait analysis);	chr14:22950944	chr14:22956957~22956978:-
OV	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-11.36	1.3e-24	-0.81	-0.57	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
OV	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-11.36	1.3e-24	-0.81	-0.57	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
OV	cis	rs8005677	0.798	rs4982711	MIMAT0019808	hsa-miR-4707-3p	-11.29	2.23e-24	-0.6	-0.57	Cognitive ability (multi-trait analysis);	chr14:22929781	chr14:22956957~22956978:-
OV	cis	rs55894132	1	rs55894132	MIMAT0019808	hsa-miR-4707-3p	-11.26	2.72e-24	-0.61	-0.57	Intelligence (multi-trait analysis);	chr14:22939628	chr14:22956957~22956978:-
OV	cis	rs8005677	0.828	rs57822749	MIMAT0019808	hsa-miR-4707-3p	-11.2	4.13e-24	-0.61	-0.57	Cognitive ability (multi-trait analysis);	chr14:22940758	chr14:22956957~22956978:-
OV	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-11.07	1.14e-23	-0.82	-0.56	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-11.07	1.14e-23	-0.82	-0.56	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-11.07	1.18e-23	-0.82	-0.56	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-11.07	1.18e-23	-0.82	-0.56	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
OV	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-10.71	1.73e-22	-0.83	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
OV	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-10.71	1.73e-22	-0.83	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
OV	cis	rs8005677	0.828	rs712486	MIMAT0019808	hsa-miR-4707-3p	-10.7	1.88e-22	-0.6	-0.55	Cognitive ability (multi-trait analysis);	chr14:22955832	chr14:22956957~22956978:-
OV	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-10.66	2.68e-22	-0.74	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-10.66	2.68e-22	-0.74	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
OV	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-10.59	4.22e-22	-0.83	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
OV	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-10.59	4.22e-22	-0.83	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-10.21	7.55e-21	-0.8	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-10.21	7.55e-21	-0.8	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
OV	cis	rs8005677	1	rs4982709	MIMAT0019808	hsa-miR-4707-3p	-10.2	7.85e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22925490	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs1956880	MIMAT0019808	hsa-miR-4707-3p	-10.19	8.45e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22924798	chr14:22956957~22956978:-
OV	cis	rs8005677	0.926	rs34344888	MIMAT0019808	hsa-miR-4707-3p	-10.18	9.06e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22918376	chr14:22956957~22956978:-
OV	cis	rs8005677	0.962	rs34917191	MIMAT0019808	hsa-miR-4707-3p	-10.18	9.06e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22918419	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs1951119	MIMAT0019808	hsa-miR-4707-3p	-10.18	9.06e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22919117	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs2295683	MIMAT0019808	hsa-miR-4707-3p	-10.18	9.06e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22919173	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs4981449	MIMAT0019808	hsa-miR-4707-3p	-10.18	9.06e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22919662	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs8014936	MIMAT0019808	hsa-miR-4707-3p	-10.17	9.96e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22905936	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs8016061	MIMAT0019808	hsa-miR-4707-3p	-10.17	9.96e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22906600	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs8005677	MIMAT0019808	hsa-miR-4707-3p	-10.17	9.96e-21	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22907469	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs8006409	MIMAT0019808	hsa-miR-4707-3p	-10.17	1e-20	-0.56	-0.53	Cognitive ability (multi-trait analysis);	chr14:22927302	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs1043209	MIMAT0019808	hsa-miR-4707-3p	10.16	1.06e-20	0.55	0.53	Cognitive ability (multi-trait analysis);	chr14:22904777	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs2295685	MIMAT0019808	hsa-miR-4707-3p	-10.12	1.45e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22928944	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs7145494	MIMAT0019808	hsa-miR-4707-3p	-10.12	1.45e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22930581	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs8006396	MIMAT0019808	hsa-miR-4707-3p	-10.11	1.5e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22911641	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs4981446	MIMAT0019808	hsa-miR-4707-3p	-10.11	1.5e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22912204	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs4982706	MIMAT0019808	hsa-miR-4707-3p	-10.11	1.5e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22912488	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs10148215	MIMAT0019808	hsa-miR-4707-3p	-10.11	1.6e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22913136	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs1956881	MIMAT0019808	hsa-miR-4707-3p	-10.1	1.74e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22924860	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs7155857	MIMAT0019808	hsa-miR-4707-3p	-10.08	1.93e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22930850	chr14:22956957~22956978:-
OV	cis	rs8005677	0.962	rs8003934	MIMAT0019808	hsa-miR-4707-3p	-10.08	1.94e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22931933	chr14:22956957~22956978:-
OV	cis	rs8005677	0.962	rs10130756	MIMAT0019808	hsa-miR-4707-3p	-10.07	2.03e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22927391	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs4982710	MIMAT0019808	hsa-miR-4707-3p	-10.07	2.09e-20	-0.55	-0.53	Cognitive ability (multi-trait analysis);	chr14:22929693	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs11157930	MIMAT0019808	hsa-miR-4707-3p	-10.06	2.3e-20	-0.56	-0.53	Cognitive ability (multi-trait analysis);	chr14:22933962	chr14:22956957~22956978:-
OV	cis	rs8005677	0.962	rs11157931	MIMAT0019808	hsa-miR-4707-3p	-10.06	2.3e-20	-0.56	-0.53	Cognitive ability (multi-trait analysis);	chr14:22933984	chr14:22956957~22956978:-
OV	cis	rs8005677	1	rs4982712	MIMAT0019808	hsa-miR-4707-3p	-9.84	1.14e-19	-0.54	-0.52	Cognitive ability (multi-trait analysis);	chr14:22934519	chr14:22956957~22956978:-
OV	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-9.77	1.92e-19	-0.78	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-9.77	1.92e-19	-0.78	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
OV	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-9.6	6.41e-19	-0.75	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-9.6	6.41e-19	-0.75	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
OV	cis	rs75358501	0.748	rs12470963	MIMAT0014995	hsa-miR-3130-5p	-9.25	7.56e-18	-0.8	-0.49	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783276~206783296:-
OV	cis	rs75358501	0.748	rs12470963	MIMAT0014995_1	hsa-miR-3130-5p	-9.25	7.56e-18	-0.8	-0.49	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783246~206783266:+
OV	cis	rs8005677	0.649	rs11629120	MIMAT0019808	hsa-miR-4707-3p	9.17	1.38e-17	0.52	0.49	Cognitive ability (multi-trait analysis);	chr14:22989248	chr14:22956957~22956978:-
OV	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-9.15	1.56e-17	-0.72	-0.49	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
OV	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-9.15	1.56e-17	-0.72	-0.49	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
OV	cis	rs8005677	0.741	rs1043675	MIMAT0019808	hsa-miR-4707-3p	9.04	3.38e-17	0.53	0.49	Cognitive ability (multi-trait analysis);	chr14:22987106	chr14:22956957~22956978:-
OV	cis	rs8005677	0.611	rs11624528	MIMAT0019808	hsa-miR-4707-3p	-8.73	2.99e-16	-0.5	-0.47	Cognitive ability (multi-trait analysis);	chr14:22989947	chr14:22956957~22956978:-
OV	cis	rs8005677	0.828	rs2295680	MIMAT0019807	hsa-miR-4707-5p	5.91	1.05e-08	0.38	0.34	Cognitive ability (multi-trait analysis);	chr14:22905226	chr14:22956998~22957020:-
OV	cis	rs8005677	0.741	rs1043675	MIMAT0019807	hsa-miR-4707-5p	5.88	1.21e-08	0.4	0.34	Cognitive ability (multi-trait analysis);	chr14:22987106	chr14:22956998~22957020:-
OV	cis	rs7829975	0.54	rs2976909	MIMAT0019728	hsa-miR-4660	-5.84	1.52e-08	-0.44	-0.34	Mood instability;	chr8:8489180	chr8:9048453~9048475:+
OV	cis	rs8005677	0.798	rs61977741	MIMAT0019807	hsa-miR-4707-5p	-5.8	1.86e-08	-0.38	-0.34	Cognitive ability (multi-trait analysis);	chr14:22931770	chr14:22956998~22957020:-
OV	cis	rs8005677	0.828	rs12589539	MIMAT0019807	hsa-miR-4707-5p	-5.79	2.01e-08	-0.39	-0.33	Cognitive ability (multi-trait analysis);	chr14:22927471	chr14:22956998~22957020:-
OV	cis	rs7072216	0.691	rs7910973	MIMAT0005878	hsa-miR-1287-5p	5.73	2.67e-08	0.38	0.33	Metabolite levels;	chr10:98406975	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	5.7	3.17e-08	0.38	0.33	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
OV	cis	rs8005677	0.828	rs35085068	MIMAT0019807	hsa-miR-4707-5p	-5.66	3.89e-08	-0.38	-0.33	Cognitive ability (multi-trait analysis);	chr14:22940700	chr14:22956998~22957020:-
OV	cis	rs8005677	0.828	rs4981451	MIMAT0019807	hsa-miR-4707-5p	-5.66	3.89e-08	-0.38	-0.33	Cognitive ability (multi-trait analysis);	chr14:22941072	chr14:22956998~22957020:-
OV	cis	rs8005677	0.798	rs4536383	MIMAT0019807	hsa-miR-4707-5p	-5.66	3.89e-08	-0.38	-0.33	Cognitive ability (multi-trait analysis);	chr14:22941717	chr14:22956998~22957020:-
OV	cis	rs8005677	0.828	rs34584578	MIMAT0019807	hsa-miR-4707-5p	-5.66	3.89e-08	-0.38	-0.33	Cognitive ability (multi-trait analysis);	chr14:22942481	chr14:22956998~22957020:-
OV	cis	rs8005677	0.828	rs8016027	MIMAT0019807	hsa-miR-4707-5p	-5.62	4.78e-08	-0.38	-0.33	Cognitive ability (multi-trait analysis);	chr14:22950944	chr14:22956998~22957020:-
OV	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	5.61	5.19e-08	0.39	0.33	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
OV	cis	rs8005677	0.828	rs57822749	MIMAT0019807	hsa-miR-4707-5p	-5.59	5.74e-08	-0.38	-0.32	Cognitive ability (multi-trait analysis);	chr14:22940758	chr14:22956998~22957020:-
OV	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	5.58	5.99e-08	0.38	0.32	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
OV	cis	rs8005677	0.798	rs4982713	MIMAT0019807	hsa-miR-4707-5p	-5.57	6.2e-08	-0.38	-0.32	Cognitive ability (multi-trait analysis);	chr14:22934893	chr14:22956998~22957020:-
OV	cis	rs8005677	0.798	rs35615180	MIMAT0019807	hsa-miR-4707-5p	-5.57	6.2e-08	-0.38	-0.32	Cognitive ability (multi-trait analysis);	chr14:22935180	chr14:22956998~22957020:-
OV	cis	rs7072216	0.727	rs942809	MIMAT0005878	hsa-miR-1287-5p	5.57	6.27e-08	0.38	0.32	Metabolite levels;	chr10:98408244	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs942804	MIMAT0005878	hsa-miR-1287-5p	5.56	6.43e-08	0.38	0.32	Metabolite levels;	chr10:98408742	chr10:98395271~98395292:-
OV	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	5.54	7.16e-08	0.26	0.32	Migraine;	chr10:103263177	chr10:103394341~103394361:-
OV	cis	rs8005677	0.798	rs4982711	MIMAT0019807	hsa-miR-4707-5p	-5.51	8.34e-08	-0.37	-0.32	Cognitive ability (multi-trait analysis);	chr14:22929781	chr14:22956998~22957020:-
OV	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	5.51	8.46e-08	0.37	0.32	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	5.51	8.46e-08	0.37	0.32	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	5.51	8.54e-08	0.37	0.32	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	5.51	8.54e-08	0.37	0.32	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	5.51	8.54e-08	0.37	0.32	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	5.51	8.54e-08	0.37	0.32	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
OV	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	5.51	8.54e-08	0.37	0.32	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
OV	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	5.51	8.54e-08	0.37	0.32	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
OV	cis	rs8005677	0.611	rs11624528	MIMAT0019807	hsa-miR-4707-5p	-5.5	8.77e-08	-0.37	-0.32	Cognitive ability (multi-trait analysis);	chr14:22989947	chr14:22956998~22957020:-
OV	cis	rs7072216	0.763	rs7091709	MIMAT0005878	hsa-miR-1287-5p	5.5	8.96e-08	0.37	0.32	Metabolite levels;	chr10:98407848	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	5.49	9.21e-08	0.37	0.32	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
OV	cis	rs8005677	1	rs4982709	MIMAT0019807	hsa-miR-4707-5p	-5.49	9.58e-08	-0.36	-0.32	Cognitive ability (multi-trait analysis);	chr14:22925490	chr14:22956998~22957020:-
OV	cis	rs55894132	1	rs55894132	MIMAT0019807	hsa-miR-4707-5p	-5.45	1.16e-07	-0.37	-0.32	Intelligence (multi-trait analysis);	chr14:22939628	chr14:22956998~22957020:-
OV	cis	rs7829975	0.56	rs17154599	MIMAT0019728	hsa-miR-4660	-5.44	1.21e-07	-0.4	-0.32	Mood instability;	chr8:8693908	chr8:9048453~9048475:+
OV	cis	rs2980436	1	rs2980436	MIMAT0019728	hsa-miR-4660	-5.44	1.22e-07	-0.43	-0.32	Schizophrenia;	chr8:8234503	chr8:9048453~9048475:+
OV	cis	rs7072216	0.763	rs942803	MIMAT0005878	hsa-miR-1287-5p	5.44	1.23e-07	0.37	0.32	Metabolite levels;	chr10:98408874	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	5.4	1.47e-07	0.37	0.31	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs12259939	MIMAT0005878	hsa-miR-1287-5p	5.38	1.6e-07	0.36	0.31	Metabolite levels;	chr10:98409264	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs9787550	MIMAT0005878	hsa-miR-1287-5p	5.38	1.6e-07	0.36	0.31	Metabolite levels;	chr10:98409294	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs12763326	MIMAT0005878	hsa-miR-1287-5p	-5.38	1.64e-07	-0.37	-0.31	Metabolite levels;	chr10:98407639	chr10:98395271~98395292:-
OV	cis	rs8005677	1	rs8006409	MIMAT0019807	hsa-miR-4707-5p	-5.35	1.91e-07	-0.36	-0.31	Cognitive ability (multi-trait analysis);	chr14:22927302	chr14:22956998~22957020:-
OV	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	5.32	2.26e-07	0.36	0.31	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
OV	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	5.32	2.26e-07	0.36	0.31	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	5.31	2.32e-07	0.36	0.31	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	5.31	2.32e-07	0.36	0.31	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	5.31	2.32e-07	0.36	0.31	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
OV	cis	rs1558648	1	rs1558648	MIMAT0019927	hsa-miR-4772-3p	-5.31	2.33e-07	-0.46	-0.31	Serum protein levels (sST2);	chr2:102193708	chr2:102432336~102432357:+
OV	cis	rs1558648	0.858	rs13014004	MIMAT0019927	hsa-miR-4772-3p	-5.3	2.41e-07	-0.44	-0.31	Serum protein levels (sST2);	chr2:102224207	chr2:102432336~102432357:+
OV	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
OV	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
OV	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
OV	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
OV	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
OV	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	5.3	2.47e-07	0.36	0.31	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	5.28	2.65e-07	0.37	0.31	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
OV	cis	rs8005677	1	rs1956881	MIMAT0019807	hsa-miR-4707-5p	-5.28	2.73e-07	-0.35	-0.31	Cognitive ability (multi-trait analysis);	chr14:22924860	chr14:22956998~22957020:-
OV	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-5.27	2.77e-07	-0.25	-0.31	Migraine;	chr10:103415374	chr10:103394341~103394361:-
OV	cis	rs1558648	0.858	rs12996377	MIMAT0019927	hsa-miR-4772-3p	-5.26	2.98e-07	-0.45	-0.31	Serum protein levels (sST2);	chr2:102214018	chr2:102432336~102432357:+
OV	cis	rs8005677	1	rs1043209	MIMAT0019807	hsa-miR-4707-5p	5.25	3.16e-07	0.35	0.31	Cognitive ability (multi-trait analysis);	chr14:22904777	chr14:22956998~22957020:-
OV	cis	rs8005677	0.828	rs712486	MIMAT0019807	hsa-miR-4707-5p	-5.24	3.24e-07	-0.36	-0.31	Cognitive ability (multi-trait analysis);	chr14:22955832	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs1956880	MIMAT0019807	hsa-miR-4707-5p	-5.23	3.5e-07	-0.34	-0.31	Cognitive ability (multi-trait analysis);	chr14:22924798	chr14:22956998~22957020:-
OV	cis	rs8005677	0.926	rs34344888	MIMAT0019807	hsa-miR-4707-5p	-5.2	3.99e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22918376	chr14:22956998~22957020:-
OV	cis	rs8005677	0.962	rs34917191	MIMAT0019807	hsa-miR-4707-5p	-5.2	3.99e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22918419	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs1951119	MIMAT0019807	hsa-miR-4707-5p	-5.2	3.99e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22919117	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs2295683	MIMAT0019807	hsa-miR-4707-5p	-5.2	3.99e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22919173	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs4981449	MIMAT0019807	hsa-miR-4707-5p	-5.2	3.99e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22919662	chr14:22956998~22957020:-
OV	cis	rs8005677	0.962	rs10130756	MIMAT0019807	hsa-miR-4707-5p	-5.18	4.41e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22927391	chr14:22956998~22957020:-
OV	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-5.14	5.24e-07	-0.59	-0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
OV	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-5.14	5.24e-07	-0.59	-0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
OV	cis	rs7072216	0.655	rs3830025	MIMAT0005878	hsa-miR-1287-5p	5.14	5.37e-07	0.36	0.3	Metabolite levels;	chr10:98416347	chr10:98395271~98395292:-
OV	cis	rs7072216	0.655	rs3830024	MIMAT0005878	hsa-miR-1287-5p	5.14	5.37e-07	0.36	0.3	Metabolite levels;	chr10:98416349	chr10:98395271~98395292:-
OV	cis	rs8005677	1	rs8014936	MIMAT0019807	hsa-miR-4707-5p	-5.1	6.43e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22905936	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs8016061	MIMAT0019807	hsa-miR-4707-5p	-5.1	6.43e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22906600	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs8005677	MIMAT0019807	hsa-miR-4707-5p	-5.1	6.43e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22907469	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs7155857	MIMAT0019807	hsa-miR-4707-5p	-5.1	6.46e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22930850	chr14:22956998~22957020:-
OV	cis	rs8005677	0.649	rs11629120	MIMAT0019807	hsa-miR-4707-5p	5.1	6.48e-07	0.35	0.3	Cognitive ability (multi-trait analysis);	chr14:22989248	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs2295685	MIMAT0019807	hsa-miR-4707-5p	-5.1	6.53e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22928944	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs7145494	MIMAT0019807	hsa-miR-4707-5p	-5.1	6.53e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22930581	chr14:22956998~22957020:-
OV	cis	rs8005677	0.962	rs8003934	MIMAT0019807	hsa-miR-4707-5p	-5.09	6.75e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22931933	chr14:22956998~22957020:-
OV	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	5.08	7e-07	0.35	0.3	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
OV	cis	rs7829975	0.56	rs56094035	MIMAT0019728	hsa-miR-4660	-5.07	7.46e-07	-0.34	-0.3	Mood instability;	chr8:8694112	chr8:9048453~9048475:+
OV	cis	rs7829975	0.539	rs4841012	MIMAT0019728	hsa-miR-4660	-5.07	7.46e-07	-0.34	-0.3	Mood instability;	chr8:8694200	chr8:9048453~9048475:+
OV	cis	rs7829975	0.56	rs4841013	MIMAT0019728	hsa-miR-4660	-5.07	7.46e-07	-0.34	-0.3	Mood instability;	chr8:8694503	chr8:9048453~9048475:+
OV	cis	rs8005677	1	rs8006396	MIMAT0019807	hsa-miR-4707-5p	-5.06	7.93e-07	-0.33	-0.3	Cognitive ability (multi-trait analysis);	chr14:22911641	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs4981446	MIMAT0019807	hsa-miR-4707-5p	-5.06	7.93e-07	-0.33	-0.3	Cognitive ability (multi-trait analysis);	chr14:22912204	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs4982706	MIMAT0019807	hsa-miR-4707-5p	-5.06	7.93e-07	-0.33	-0.3	Cognitive ability (multi-trait analysis);	chr14:22912488	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs10148215	MIMAT0019807	hsa-miR-4707-5p	-5.05	8.18e-07	-0.33	-0.3	Cognitive ability (multi-trait analysis);	chr14:22913136	chr14:22956998~22957020:-
OV	cis	rs8005677	1	rs4982710	MIMAT0019807	hsa-miR-4707-5p	-5.05	8.33e-07	-0.34	-0.3	Cognitive ability (multi-trait analysis);	chr14:22929693	chr14:22956998~22957020:-
OV	cis	rs4578769	0.55	rs9956087	MIMAT0019871	hsa-miR-4741	5.04	8.58e-07	0.31	0.3	Eosinophil percentage of white cells;	chr18:23030538	chr18:22933407~22933429:+
OV	cis	rs4578769	0.55	rs6507452	MIMAT0019871	hsa-miR-4741	5.04	8.58e-07	0.31	0.3	Eosinophil percentage of white cells;	chr18:23032275	chr18:22933407~22933429:+
OV	cis	rs12962334	0.555	rs9954649	MIMAT0019871	hsa-miR-4741	5.04	8.58e-07	0.31	0.3	Breast cancer;	chr18:23033307	chr18:22933407~22933429:+
OV	cis	rs4578769	0.505	rs9946743	MIMAT0019871	hsa-miR-4741	5.04	8.58e-07	0.31	0.3	Eosinophil percentage of white cells;	chr18:23033394	chr18:22933407~22933429:+
OV	cis	rs4851551	0.543	rs11887842	MIMAT0019927	hsa-miR-4772-3p	-5.04	8.78e-07	-0.49	-0.3	Blood protein levels;	chr2:102223018	chr2:102432336~102432357:+
OV	cis	rs7829975	0.617	rs4841071	MIMAT0019728	hsa-miR-4660	5.03	9.22e-07	0.32	0.3	Mood instability;	chr8:8933634	chr8:9048453~9048475:+
OV	cis	rs12962334	0.555	rs9959556	MIMAT0019871	hsa-miR-4741	5	1.06e-06	0.31	0.29	Breast cancer;	chr18:23011982	chr18:22933407~22933429:+
OV	cis	rs4578769	0.531	rs4800443	MIMAT0019871	hsa-miR-4741	5	1.06e-06	0.31	0.29	Eosinophil percentage of white cells;	chr18:23015139	chr18:22933407~22933429:+
OV	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	4.99	1.09e-06	0.23	0.29	Migraine;	chr10:103236031	chr10:103394341~103394361:-
OV	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-4.98	1.12e-06	-0.57	-0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
OV	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-4.98	1.12e-06	-0.57	-0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
OV	cis	rs7072216	0.621	rs3750604	MIMAT0005878	hsa-miR-1287-5p	4.97	1.2e-06	0.38	0.29	Metabolite levels;	chr10:98415824	chr10:98395271~98395292:-
OV	cis	rs9675999	1	rs9675999	MIMAT0019871	hsa-miR-4741	4.96	1.27e-06	0.31	0.29	Breast cancer;	chr18:23047728	chr18:22933407~22933429:+
OV	cis	rs7072216	0.621	rs3750605	MIMAT0005878	hsa-miR-1287-5p	4.94	1.39e-06	0.37	0.29	Metabolite levels;	chr10:98415897	chr10:98395271~98395292:-
OV	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	4.94	1.41e-06	0.22	0.29	Migraine;	chr10:103402122	chr10:103394341~103394361:-
OV	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	4.93	1.47e-06	0.37	0.29	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
OV	cis	rs4851551	0.543	rs17026757	MIMAT0019927	hsa-miR-4772-3p	-4.92	1.49e-06	-0.48	-0.29	Blood protein levels;	chr2:102197452	chr2:102432336~102432357:+
OV	cis	rs8005677	1	rs11157930	MIMAT0019807	hsa-miR-4707-5p	-4.92	1.53e-06	-0.33	-0.29	Cognitive ability (multi-trait analysis);	chr14:22933962	chr14:22956998~22957020:-
OV	cis	rs8005677	0.962	rs11157931	MIMAT0019807	hsa-miR-4707-5p	-4.92	1.53e-06	-0.33	-0.29	Cognitive ability (multi-trait analysis);	chr14:22933984	chr14:22956998~22957020:-
OV	cis	rs4851551	0.543	rs11903354	MIMAT0019927	hsa-miR-4772-3p	-4.92	1.55e-06	-0.48	-0.29	Blood protein levels;	chr2:102193968	chr2:102432336~102432357:+
OV	cis	rs7829975	0.742	rs1533058	MIMAT0019728	hsa-miR-4660	4.91	1.59e-06	0.35	0.29	Mood instability;	chr8:8827680	chr8:9048453~9048475:+
OV	cis	rs7072216	0.621	rs11189595	MIMAT0005878	hsa-miR-1287-5p	4.9	1.68e-06	0.37	0.29	Metabolite levels;	chr10:98407565	chr10:98395271~98395292:-
OV	cis	rs8005677	1	rs4982712	MIMAT0019807	hsa-miR-4707-5p	-4.89	1.72e-06	-0.33	-0.29	Cognitive ability (multi-trait analysis);	chr14:22934519	chr14:22956998~22957020:-
OV	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-4.88	1.8e-06	-0.23	-0.29	Migraine;	chr10:103315955	chr10:103394341~103394361:-
OV	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-4.88	1.8e-06	-0.23	-0.29	Migraine;	chr10:103338267	chr10:103394341~103394361:-
OV	cis	rs4578769	0.55	rs11082258	MIMAT0019871	hsa-miR-4741	4.88	1.81e-06	0.31	0.29	Eosinophil percentage of white cells;	chr18:23037401	chr18:22933407~22933429:+
OV	cis	rs4578769	0.55	rs4280358	MIMAT0019871	hsa-miR-4741	4.88	1.81e-06	0.31	0.29	Eosinophil percentage of white cells;	chr18:23037844	chr18:22933407~22933429:+
OV	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-4.88	1.82e-06	-0.23	-0.29	Migraine;	chr10:103286250	chr10:103394341~103394361:-
OV	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-4.88	1.82e-06	-0.23	-0.29	Migraine;	chr10:103286932	chr10:103394341~103394361:-
OV	cis	rs4578769	0.55	rs9961760	MIMAT0019871	hsa-miR-4741	4.87	1.9e-06	0.3	0.29	Eosinophil percentage of white cells;	chr18:23021545	chr18:22933407~22933429:+
OV	cis	rs2980439	0.87	rs2945230	MIMAT0019728	hsa-miR-4660	4.86	2.02e-06	0.31	0.29	Neuroticism;	chr8:8252414	chr8:9048453~9048475:+
OV	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-4.85	2.14e-06	-0.21	-0.29	Migraine;	chr10:103307280	chr10:103394341~103394361:-
OV	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	4.84	2.16e-06	0.33	0.29	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	4.84	2.16e-06	0.33	0.29	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
OV	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	4.84	2.16e-06	0.33	0.29	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
OV	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-4.84	2.19e-06	-0.23	-0.29	Migraine;	chr10:103365694	chr10:103394341~103394361:-
OV	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-4.84	2.19e-06	-0.23	-0.29	Migraine;	chr10:103369141	chr10:103394341~103394361:-
OV	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-4.83	2.36e-06	-0.23	-0.28	Migraine;	chr10:103295206	chr10:103394341~103394361:-
OV	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-4.83	2.36e-06	-0.23	-0.28	Migraine;	chr10:103296155	chr10:103394341~103394361:-
OV	cis	rs4851551	0.543	rs1997503	MIMAT0019927	hsa-miR-4772-3p	-4.82	2.43e-06	-0.44	-0.28	Blood protein levels;	chr2:102192775	chr2:102432336~102432357:+
OV	cis	rs2911280	0.764	rs9319570	MIMAT0030429	hsa-miR-7854-3p	-4.82	2.46e-06	-0.66	-0.28	Dehydroepiandrosterone sulphate levels;	chr16:81545828	chr16:81533942~81533962:+
OV	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	4.81	2.53e-06	0.21	0.28	Migraine;	chr10:103347713	chr10:103394341~103394361:-
OV	cis	rs7072216	0.763	rs4475861	MIMAT0005878	hsa-miR-1287-5p	4.79	2.72e-06	0.33	0.28	Metabolite levels;	chr10:98405232	chr10:98395271~98395292:-
OV	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-4.78	2.95e-06	-0.32	-0.28	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
OV	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	4.77	3.01e-06	0.33	0.28	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
OV	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	4.77	3.01e-06	0.33	0.28	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
OV	cis	rs4578769	0.55	rs6417085	MIMAT0019871	hsa-miR-4741	4.77	3.12e-06	0.3	0.28	Eosinophil percentage of white cells;	chr18:23041335	chr18:22933407~22933429:+
OV	cis	rs4578769	0.55	rs6507456	MIMAT0019871	hsa-miR-4741	4.77	3.12e-06	0.3	0.28	Eosinophil percentage of white cells;	chr18:23042023	chr18:22933407~22933429:+
OV	cis	rs4578769	0.513	rs9956441	MIMAT0019871	hsa-miR-4741	4.77	3.12e-06	0.3	0.28	Eosinophil percentage of white cells;	chr18:23042524	chr18:22933407~22933429:+
OV	cis	rs739525	0.518	rs178268	MIMAT0022726	hsa-miR-1306-5p	4.76	3.22e-06	0.25	0.28	Testicular germ cell tumor;	chr22:20975977	chr22:20086072~20086093:+
OV	cis	rs4578769	0.55	rs9945620	MIMAT0019871	hsa-miR-4741	4.76	3.24e-06	0.29	0.28	Eosinophil percentage of white cells;	chr18:22997367	chr18:22933407~22933429:+
OV	cis	rs4578769	0.55	rs2305886	MIMAT0019871	hsa-miR-4741	4.76	3.24e-06	0.29	0.28	Eosinophil percentage of white cells;	chr18:22997493	chr18:22933407~22933429:+
OV	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-4.75	3.29e-06	-0.23	-0.28	Migraine;	chr10:103394332	chr10:103394341~103394361:-
OV	cis	rs7636293	1	rs9816623	MIMAT0027553	hsa-miR-6826-3p	-4.73	3.63e-06	-0.31	-0.28	Height;	chr3:129323873	chr3:129272222~129272243:+
OV	cis	rs739525	0.518	rs178268	MIMAT0000455	hsa-miR-185-5p	4.73	3.69e-06	0.22	0.28	Testicular germ cell tumor;	chr22:20975977	chr22:20033153~20033174:+
OV	cis	rs4808779	0.884	rs7247222	MIMAT0015070	hsa-miR-3188	4.73	3.73e-06	0.31	0.28	Granulocyte percentage of myeloid white cells;	chr19:18282063	chr19:18282129~18282151:+
OV	cis	rs7829975	0.577	rs940030	MIMAT0019728	hsa-miR-4660	-4.71	4.04e-06	-0.31	-0.28	Mood instability;	chr8:8689418	chr8:9048453~9048475:+
OV	cis	rs2150052	0.902	rs877544	MIMAT0030017	hsa-miR-7702	-4.68	4.62e-06	-0.26	-0.28	Neutrophil percentage of white cells;Birth weight;	chr9:111133465	chr9:111271193~111271214:-
OV	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-4.67	4.85e-06	-0.5	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
OV	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-4.67	4.85e-06	-0.5	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
OV	cis	rs997154	0.655	rs4981454	MIMAT0019808	hsa-miR-4707-3p	-4.66	4.91e-06	-0.35	-0.28	Primary tooth development (number of teeth);Primary tooth development (time to first tooth eruption);	chr14:22952977	chr14:22956957~22956978:-
OV	cis	rs4851551	0.543	rs35918372	MIMAT0019927	hsa-miR-4772-3p	-4.66	4.92e-06	-0.51	-0.28	Blood protein levels;	chr2:102202803	chr2:102432336~102432357:+
OV	cis	rs4448343	0.736	rs2297086	MIMAT0000418	hsa-miR-23b-3p	4.65	5.22e-06	0.3	0.27	Height;	chr9:95477838	chr9:95085265~95085287:+
OV	cis	rs4448343	0.736	rs2297088	MIMAT0000418	hsa-miR-23b-3p	4.65	5.34e-06	0.26	0.27	Height;	chr9:95480702	chr9:95085265~95085287:+
OV	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-4.65	5.35e-06	-0.2	-0.27	Migraine;	chr10:103375562	chr10:103394341~103394361:-
OV	cis	rs4448343	0.736	rs2297086	MIMAT0000419	hsa-miR-27b-3p	4.64	5.5e-06	0.3	0.27	Height;	chr9:95477838	chr9:95085505~95085525:+
OV	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-4.63	5.62e-06	-0.2	-0.27	Migraine;	chr10:103384531	chr10:103394341~103394361:-
OV	cis	rs4578769	0.55	rs12958492	MIMAT0019871	hsa-miR-4741	4.63	5.71e-06	0.28	0.27	Eosinophil percentage of white cells;	chr18:22988974	chr18:22933407~22933429:+
OV	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-4.63	5.73e-06	-0.2	-0.27	Migraine;	chr10:103386935	chr10:103394341~103394361:-
OV	cis	rs7072216	0.77	rs1739	MIMAT0005878	hsa-miR-1287-5p	4.62	6.01e-06	0.31	0.27	Metabolite levels;	chr10:98416582	chr10:98395271~98395292:-
OV	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-4.61	6.19e-06	-0.2	-0.27	Migraine;	chr10:103379204	chr10:103394341~103394361:-
OV	cis	rs4578769	0.569	rs3851822	MIMAT0019871	hsa-miR-4741	-4.61	6.22e-06	-0.28	-0.27	Eosinophil percentage of white cells;	chr18:22882829	chr18:22933407~22933429:+
OV	cis	rs2150052	0.84	rs10817149	MIMAT0030017	hsa-miR-7702	-4.61	6.32e-06	-0.26	-0.27	Neutrophil percentage of white cells;Birth weight;	chr9:111115131	chr9:111271193~111271214:-
OV	cis	rs4578769	0.55	rs4474794	MIMAT0019871	hsa-miR-4741	4.6	6.41e-06	0.28	0.27	Eosinophil percentage of white cells;	chr18:22987010	chr18:22933407~22933429:+
OV	cis	rs2980439	0.818	rs2945249	MIMAT0019728	hsa-miR-4660	4.6	6.44e-06	0.4	0.27	Neuroticism;	chr8:8237204	chr8:9048453~9048475:+
OV	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-4.6	6.55e-06	-0.2	-0.27	Migraine;	chr10:103367521	chr10:103394341~103394361:-
OV	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-4.6	6.55e-06	-0.2	-0.27	Migraine;	chr10:103367951	chr10:103394341~103394361:-
OV	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-4.6	6.55e-06	-0.2	-0.27	Migraine;	chr10:103353944	chr10:103394341~103394361:-
OV	cis	rs4578769	0.55	rs4800435	MIMAT0019871	hsa-miR-4741	4.6	6.62e-06	0.28	0.27	Eosinophil percentage of white cells;	chr18:22862923	chr18:22933407~22933429:+
OV	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-4.6	6.62e-06	-0.2	-0.27	Migraine;	chr10:103356299	chr10:103394341~103394361:-
OV	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-4.6	6.62e-06	-0.2	-0.27	Migraine;	chr10:103358705	chr10:103394341~103394361:-
OV	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-4.6	6.62e-06	-0.2	-0.27	Migraine;	chr10:103358719	chr10:103394341~103394361:-
OV	cis	rs7072216	0.763	rs7914401	MIMAT0005878	hsa-miR-1287-5p	4.59	7e-06	0.31	0.27	Metabolite levels;	chr10:98404171	chr10:98395271~98395292:-
OV	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-4.58	7.09e-06	-0.2	-0.27	Migraine;	chr10:103279291	chr10:103394341~103394361:-
OV	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-4.58	7.2e-06	-0.22	-0.27	Migraine;	chr10:103254113	chr10:103394341~103394361:-
OV	cis	rs2150052	0.805	rs1888190	MIMAT0030017	hsa-miR-7702	-4.55	8.12e-06	-0.25	-0.27	Neutrophil percentage of white cells;Birth weight;	chr9:111128720	chr9:111271193~111271214:-
OV	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-4.55	8.18e-06	-0.2	-0.27	Migraine;	chr10:103348698	chr10:103394341~103394361:-
OV	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-4.55	8.28e-06	-0.2	-0.27	Migraine;	chr10:103395309	chr10:103394341~103394361:-
OV	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-4.55	8.28e-06	-0.2	-0.27	Migraine;	chr10:103395888	chr10:103394341~103394361:-
OV	cis	rs7829975	0.582	rs448231	MIMAT0019728	hsa-miR-4660	-4.54	8.43e-06	-0.3	-0.27	Mood instability;	chr8:8932549	chr8:9048453~9048475:+
OV	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	4.54	8.55e-06	0.22	0.27	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
OV	cis	rs4578769	0.569	rs12605341	MIMAT0019871	hsa-miR-4741	-4.53	8.83e-06	-0.27	-0.27	Eosinophil percentage of white cells;	chr18:22803011	chr18:22933407~22933429:+
OV	cis	rs7072216	0.555	rs2296433	MIMAT0005878	hsa-miR-1287-5p	4.53	8.93e-06	0.35	0.27	Metabolite levels;	chr10:98424305	chr10:98395271~98395292:-
OV	cis	rs7072216	0.555	rs2296432	MIMAT0005878	hsa-miR-1287-5p	4.53	8.93e-06	0.35	0.27	Metabolite levels;	chr10:98424306	chr10:98395271~98395292:-
OV	cis	rs7636293	1	rs7636293	MIMAT0027553	hsa-miR-6826-3p	4.53	9.08e-06	0.3	0.27	Height;	chr3:129327063	chr3:129272222~129272243:+
OV	cis	rs4578769	0.589	rs12606787	MIMAT0019871	hsa-miR-4741	4.52	9.26e-06	0.28	0.27	Eosinophil percentage of white cells;	chr18:22830392	chr18:22933407~22933429:+
OV	cis	rs4578769	0.569	rs4800433	MIMAT0019871	hsa-miR-4741	4.52	9.38e-06	0.28	0.27	Eosinophil percentage of white cells;	chr18:22816691	chr18:22933407~22933429:+
OV	cis	rs4578769	0.569	rs11082155	MIMAT0019871	hsa-miR-4741	4.52	9.38e-06	0.28	0.27	Eosinophil percentage of white cells;	chr18:22824527	chr18:22933407~22933429:+
OV	cis	rs4578769	0.569	rs4289091	MIMAT0019871	hsa-miR-4741	4.52	9.38e-06	0.28	0.27	Eosinophil percentage of white cells;	chr18:22825856	chr18:22933407~22933429:+
OV	cis	rs4578769	0.569	rs12956367	MIMAT0019871	hsa-miR-4741	4.52	9.38e-06	0.28	0.27	Eosinophil percentage of white cells;	chr18:22833742	chr18:22933407~22933429:+
OV	cis	rs4578769	0.55	rs4471804	MIMAT0019871	hsa-miR-4741	-4.51	9.7e-06	-0.28	-0.27	Eosinophil percentage of white cells;	chr18:22996218	chr18:22933407~22933429:+
OV	cis	rs997154	0.655	rs7147394	MIMAT0019808	hsa-miR-4707-3p	-4.5	1.04e-05	-0.34	-0.27	Primary tooth development (number of teeth);Primary tooth development (time to first tooth eruption);	chr14:22941845	chr14:22956957~22956978:-
OV	cis	rs7072216	0.77	rs1737	MIMAT0005878	hsa-miR-1287-5p	4.48	1.1e-05	0.29	0.27	Metabolite levels;	chr10:98416609	chr10:98395271~98395292:-
OV	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-4.48	1.12e-05	-0.2	-0.27	Migraine;	chr10:103289348	chr10:103394341~103394361:-
OV	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-4.48	1.12e-05	-0.2	-0.27	Migraine;	chr10:103292867	chr10:103394341~103394361:-
OV	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-4.48	1.12e-05	-0.2	-0.27	Migraine;	chr10:103293183	chr10:103394341~103394361:-
OV	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-4.48	1.12e-05	-0.2	-0.27	Migraine;	chr10:103293219	chr10:103394341~103394361:-
OV	cis	rs2150052	0.837	rs2150054	MIMAT0030017	hsa-miR-7702	-4.48	1.13e-05	-0.25	-0.27	Neutrophil percentage of white cells;Birth weight;	chr9:111124067	chr9:111271193~111271214:-
OV	cis	rs7829975	0.539	rs940031	MIMAT0019728	hsa-miR-4660	-4.47	1.14e-05	-0.3	-0.26	Mood instability;	chr8:8689338	chr8:9048453~9048475:+
OV	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-4.47	1.16e-05	-0.2	-0.26	Migraine;	chr10:103297804	chr10:103394341~103394361:-
OV	cis	rs17730929	0.722	rs72641620	MIMAT0005923	hsa-miR-1269a	-4.46	1.19e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66265652	chr4:66276890~66276911:+
OV	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-4.46	1.21e-05	-0.2	-0.26	Migraine;	chr10:103389790	chr10:103394341~103394361:-
OV	cis	rs17730929	0.722	rs10517972	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66263635	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs10517970	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66263813	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs10517969	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66263852	chr4:66276890~66276911:+
OV	cis	rs17730929	0.591	rs72641615	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66263912	chr4:66276890~66276911:+
OV	cis	rs17730929	0.591	rs72641616	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66263923	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs17838961	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66264579	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13107500	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66265657	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13139833	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66265742	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13107954	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66265877	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13140283	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66265990	chr4:66276890~66276911:+
OV	cis	rs17730929	0.656	rs13111848	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266020	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13113516	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266094	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13111921	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266095	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13145575	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266161	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13113894	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266216	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13112620	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266350	chr4:66276890~66276911:+
OV	cis	rs17730929	0.656	rs13115053	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266794	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13113717	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266893	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13147393	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266945	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13147401	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266956	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13113927	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66266990	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13119186	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267060	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13119418	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267145	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs35943387	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267443	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs35358552	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267628	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs34134312	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267647	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs36044013	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267679	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13148783	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267739	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13122552	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267818	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs13148985	MIMAT0005923	hsa-miR-1269a	-4.45	1.29e-05	-0.66	-0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66267827	chr4:66276890~66276911:+
OV	cis	rs17730929	0.722	rs10517974	MIMAT0005923	hsa-miR-1269a	4.45	1.29e-05	0.66	0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66263513	chr4:66276890~66276911:+
OV	cis	rs2948294	0.588	rs4840913	MIMAT0019728	hsa-miR-4660	4.44	1.31e-05	0.36	0.26	Red cell distribution width;	chr8:8259384	chr8:9048453~9048475:+
OV	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-4.44	1.33e-05	-0.19	-0.26	Migraine;	chr10:103278698	chr10:103394341~103394361:-
OV	cis	rs4578769	0.55	rs4517887	MIMAT0019871	hsa-miR-4741	-4.42	1.47e-05	-0.27	-0.26	Eosinophil percentage of white cells;	chr18:22994715	chr18:22933407~22933429:+
OV	cis	rs4578769	0.55	rs4635434	MIMAT0019871	hsa-miR-4741	-4.42	1.47e-05	-0.27	-0.26	Eosinophil percentage of white cells;	chr18:22996032	chr18:22933407~22933429:+
OV	cis	rs4808779	0.884	rs12973608	MIMAT0015070	hsa-miR-3188	4.41	1.5e-05	0.29	0.26	Granulocyte percentage of myeloid white cells;	chr19:18287220	chr19:18282129~18282151:+
OV	cis	rs2150052	0.84	rs1411424	MIMAT0030017	hsa-miR-7702	-4.4	1.54e-05	-0.25	-0.26	Neutrophil percentage of white cells;Birth weight;	chr9:111130683	chr9:111271193~111271214:-
OV	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-4.4	1.55e-05	-0.19	-0.26	Migraine;	chr10:103279822	chr10:103394341~103394361:-
OV	cis	rs35141484	1	rs35141484	MIMAT0003239	hsa-miR-574-3p	-4.4	1.56e-05	-0.39	-0.26	Asthma (childhood onset);	chr4:39086721	chr4:38868092~38868113:+
OV	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-4.4	1.58e-05	-0.33	-0.26	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
OV	cis	rs4851551	0.619	rs34722443	MIMAT0019927	hsa-miR-4772-3p	-4.4	1.58e-05	-0.5	-0.26	Blood protein levels;	chr2:102223859	chr2:102432336~102432357:+
OV	cis	rs4808779	0.924	rs12980403	MIMAT0015070	hsa-miR-3188	4.39	1.61e-05	0.29	0.26	Granulocyte percentage of myeloid white cells;	chr19:18287329	chr19:18282129~18282151:+
OV	cis	rs2150052	0.811	rs10283911	MIMAT0030017	hsa-miR-7702	-4.39	1.64e-05	-0.25	-0.26	Neutrophil percentage of white cells;Birth weight;	chr9:111120402	chr9:111271193~111271214:-
OV	cis	rs2150052	0.84	rs10980778	MIMAT0030017	hsa-miR-7702	-4.39	1.64e-05	-0.25	-0.26	Neutrophil percentage of white cells;Birth weight;	chr9:111121220	chr9:111271193~111271214:-
OV	cis	rs189798	0.592	rs10111263	MIMAT0019728	hsa-miR-4660	-4.39	1.66e-05	-0.33	-0.26	Myopia (pathological);	chr8:9111923	chr8:9048453~9048475:+
OV	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-4.39	1.67e-05	-0.19	-0.26	Migraine;	chr10:103284400	chr10:103394341~103394361:-
OV	cis	rs4851551	0.543	rs62156407	MIMAT0019927	hsa-miR-4772-3p	-4.38	1.68e-05	-0.52	-0.26	Blood protein levels;	chr2:102208162	chr2:102432336~102432357:+
OV	cis	rs7829975	0.659	rs4382480	MIMAT0019728	hsa-miR-4660	4.38	1.68e-05	0.29	0.26	Mood instability;	chr8:8863963	chr8:9048453~9048475:+
OV	cis	rs10256972	0.552	rs2960837	MIMAT0004702	hsa-miR-339-3p	4.38	1.71e-05	0.29	0.26	Endometriosis;Longevity;	chr7:1164321	chr7:1022955~1022977:-
OV	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	4.38	1.73e-05	0.2	0.26	Migraine;	chr10:103241753	chr10:103394341~103394361:-
OV	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-4.37	1.77e-05	-0.19	-0.26	Migraine;	chr10:103273985	chr10:103394341~103394361:-
OV	cis	rs4808779	0.924	rs12610373	MIMAT0015070	hsa-miR-3188	4.37	1.77e-05	0.29	0.26	Granulocyte percentage of myeloid white cells;	chr19:18287474	chr19:18282129~18282151:+
OV	cis	rs4578769	0.55	rs9949333	MIMAT0019871	hsa-miR-4741	4.36	1.84e-05	0.27	0.26	Eosinophil percentage of white cells;	chr18:22815080	chr18:22933407~22933429:+
OV	cis	rs4578769	0.569	rs9962620	MIMAT0019871	hsa-miR-4741	4.36	1.84e-05	0.27	0.26	Eosinophil percentage of white cells;	chr18:22815811	chr18:22933407~22933429:+
OV	cis	rs4578769	0.569	rs1448769	MIMAT0019871	hsa-miR-4741	4.35	1.91e-05	0.26	0.26	Eosinophil percentage of white cells;	chr18:22838322	chr18:22933407~22933429:+
OV	cis	rs453301	0.624	rs330049	MIMAT0019728	hsa-miR-4660	4.35	1.91e-05	0.34	0.26	Joint mobility (Beighton score);	chr8:9229789	chr8:9048453~9048475:+
OV	cis	rs7636293	0.897	rs7623428	MIMAT0027553	hsa-miR-6826-3p	-4.35	1.96e-05	-0.29	-0.26	Height;	chr3:129330050	chr3:129272222~129272243:+
OV	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-4.34	1.99e-05	-0.19	-0.26	Migraine;	chr10:103305652	chr10:103394341~103394361:-
OV	cis	rs7072216	0.763	rs2147901	MIMAT0005878	hsa-miR-1287-5p	-4.34	2e-05	-0.3	-0.26	Metabolite levels;	chr10:98405739	chr10:98395271~98395292:-
OV	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	4.33	2.1e-05	0.19	0.26	Migraine;	chr10:103237257	chr10:103394341~103394361:-
OV	cis	rs4578769	0.569	rs12966840	MIMAT0019871	hsa-miR-4741	-4.32	2.17e-05	-0.27	-0.26	Eosinophil percentage of white cells;	chr18:22856911	chr18:22933407~22933429:+
OV	cis	rs10256972	0.552	rs2949195	MIMAT0004702	hsa-miR-339-3p	4.32	2.18e-05	0.28	0.26	Endometriosis;Longevity;	chr7:1163069	chr7:1022955~1022977:-
OV	cis	rs7636293	1	rs6439169	MIMAT0027553	hsa-miR-6826-3p	-4.32	2.23e-05	-0.29	-0.26	Height;	chr3:129332792	chr3:129272222~129272243:+
OV	cis	rs11603691	1	rs2155233	MIMAT0004593	hsa-miR-130a-5p	4.31	2.26e-05	0.4	0.26	Low high density lipoprotein cholesterol levels;	chr11:57274518	chr11:57641212~57641233:+
OV	cis	rs10256972	0.552	rs2949192	MIMAT0004702	hsa-miR-339-3p	4.31	2.31e-05	0.28	0.26	Endometriosis;Longevity;	chr7:1164205	chr7:1022955~1022977:-
OV	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.37e-05	-0.19	-0.26	Migraine;	chr10:103299551	chr10:103394341~103394361:-
OV	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.39e-05	-0.19	-0.26	Migraine;	chr10:103309363	chr10:103394341~103394361:-
OV	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.43e-05	-0.19	-0.26	Migraine;	chr10:103283532	chr10:103394341~103394361:-
OV	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.43e-05	-0.19	-0.26	Migraine;	chr10:103284207	chr10:103394341~103394361:-
OV	cis	rs7208859	0.623	rs122898	MIMAT0001340	hsa-miR-423-3p	4.29	2.56e-05	0.23	0.25	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30578236	chr17:30117131~30117153:+
OV	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-4.28	2.61e-05	-0.19	-0.25	Migraine;	chr10:103299082	chr10:103394341~103394361:-
OV	cis	rs2150052	0.84	rs12554247	MIMAT0030017	hsa-miR-7702	-4.26	2.84e-05	-0.24	-0.25	Neutrophil percentage of white cells;Birth weight;	chr9:111116931	chr9:111271193~111271214:-
OV	cis	rs6584202	0.589	rs10883094	MIMAT0005878	hsa-miR-1287-5p	4.25	3.02e-05	0.29	0.25	Obesity-related traits;	chr10:98428349	chr10:98395271~98395292:-
OV	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-4.23	3.25e-05	-0.18	-0.25	Migraine;	chr10:103317367	chr10:103394341~103394361:-
OV	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-4.23	3.25e-05	-0.18	-0.25	Migraine;	chr10:103319682	chr10:103394341~103394361:-
OV	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-4.22	3.4e-05	-0.18	-0.25	Migraine;	chr10:103241568	chr10:103394341~103394361:-
OV	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-4.2	3.6e-05	-0.18	-0.25	Migraine;	chr10:103273871	chr10:103394341~103394361:-
OV	cis	rs453301	0.653	rs1562211	MIMAT0019728	hsa-miR-4660	-4.2	3.64e-05	-0.29	-0.25	Joint mobility (Beighton score);	chr8:9044914	chr8:9048453~9048475:+
OV	cis	rs10256972	0.552	rs2960830	MIMAT0004702	hsa-miR-339-3p	4.2	3.72e-05	0.27	0.25	Endometriosis;Longevity;	chr7:1161005	chr7:1022955~1022977:-
OV	cis	rs4869419	0.502	rs6861722	MIMAT0011777	hsa-miR-2277-3p	-4.19	3.86e-05	-0.33	-0.25	Natriuretic peptide levels;	chr5:93028722	chr5:93620710~93620730:-
OV	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-4.18	4.02e-05	-0.31	-0.25	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
OV	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-4.18	4.05e-05	-0.48	-0.25	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
OV	cis	rs10256972	0.626	rs62433138	MIMAT0004702	hsa-miR-339-3p	4.17	4.07e-05	0.26	0.25	Endometriosis;Longevity;	chr7:1011241	chr7:1022955~1022977:-
OV	cis	rs7636293	0.86	rs55862617	MIMAT0027553	hsa-miR-6826-3p	-4.17	4.11e-05	-0.28	-0.25	Height;	chr3:129330693	chr3:129272222~129272243:+
OV	cis	rs7636293	0.86	rs55894447	MIMAT0027553	hsa-miR-6826-3p	-4.17	4.11e-05	-0.28	-0.25	Height;	chr3:129330694	chr3:129272222~129272243:+
OV	cis	rs7636293	0.86	rs55893559	MIMAT0027553	hsa-miR-6826-3p	-4.17	4.11e-05	-0.28	-0.25	Height;	chr3:129330695	chr3:129272222~129272243:+
OV	cis	rs2980439	0.846	rs2980437	MIMAT0019728	hsa-miR-4660	-4.17	4.13e-05	-0.37	-0.25	Neuroticism;	chr8:8237241	chr8:9048453~9048475:+
OV	cis	rs11603691	1	rs518272	MIMAT0004593	hsa-miR-130a-5p	4.17	4.2e-05	0.37	0.25	Low high density lipoprotein cholesterol levels;	chr11:57250083	chr11:57641212~57641233:+
OV	cis	rs4808779	0.924	rs11086102	MIMAT0015070	hsa-miR-3188	4.17	4.21e-05	0.28	0.25	Granulocyte percentage of myeloid white cells;	chr19:18287818	chr19:18282129~18282151:+
OV	cis	rs10256972	0.577	rs4999286	MIMAT0004702	hsa-miR-339-3p	4.16	4.39e-05	0.27	0.25	Endometriosis;Longevity;	chr7:1159870	chr7:1022955~1022977:-
OV	cis	rs7829975	0.593	rs2921077	MIMAT0019728	hsa-miR-4660	4.15	4.42e-05	0.28	0.25	Mood instability;	chr8:8446992	chr8:9048453~9048475:+
OV	cis	rs10256972	0.552	rs2960831	MIMAT0004702	hsa-miR-339-3p	4.15	4.5e-05	0.27	0.25	Endometriosis;Longevity;	chr7:1161556	chr7:1022955~1022977:-
OV	cis	rs35851103	0.507	rs6601649	MIMAT0003266	hsa-miR-598-3p	4.14	4.6e-05	0.35	0.25	Neuroticism;	chr8:11999808	chr8:11035221~11035242:-
OV	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	4.14	4.62e-05	0.18	0.25	Migraine;	chr10:103248169	chr10:103394341~103394361:-
OV	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	4.14	4.62e-05	0.18	0.25	Migraine;	chr10:103249329	chr10:103394341~103394361:-
OV	cis	rs6669384	0.737	rs882198	MIMAT0004515	hsa-miR-29b-2-5p	4.14	4.71e-05	0.27	0.25	Immune response to measles vaccine (measles-specific neutralising antibody titre);	chr1:207863164	chr1:207802492~207802513:-
OV	cis	rs7636293	0.964	rs10804589	MIMAT0027553	hsa-miR-6826-3p	-4.12	5.09e-05	-0.28	-0.25	Height;	chr3:129331778	chr3:129272222~129272243:+
OV	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.24e-05	-0.3	-0.24	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
OV	cis	rs2066940	0.54	rs2045562	MIMAT0000510	hsa-miR-320a-3p	4.11	5.28e-05	0.34	0.24	Sitting height ratio;	chr8:21350726	chr8:22244975~22244996:-
OV	cis	rs4808779	0.787	rs10406080	MIMAT0015070	hsa-miR-3188	4.11	5.34e-05	0.28	0.24	Granulocyte percentage of myeloid white cells;	chr19:18291332	chr19:18282129~18282151:+
OV	cis	rs2911280	0.764	rs7196069	MIMAT0030429	hsa-miR-7854-3p	-4.1	5.42e-05	-0.56	-0.24	Dehydroepiandrosterone sulphate levels;	chr16:81527851	chr16:81533942~81533962:+
OV	cis	rs11603691	1	rs2155232	MIMAT0004593	hsa-miR-130a-5p	4.07	6.18e-05	0.37	0.24	Low high density lipoprotein cholesterol levels;	chr11:57273904	chr11:57641212~57641233:+
OV	cis	rs4448343	0.736	rs2236407	MIMAT0000418	hsa-miR-23b-3p	4.06	6.51e-05	0.23	0.24	Height;	chr9:95475514	chr9:95085265~95085287:+
OV	cis	rs7829975	0.742	rs1533059	MIMAT0019728	hsa-miR-4660	-4.05	6.72e-05	-0.27	-0.24	Mood instability;	chr8:8827443	chr8:9048453~9048475:+
OV	cis	rs11603691	0.892	rs668408	MIMAT0004593	hsa-miR-130a-5p	-4.04	7.12e-05	-0.36	-0.24	Low high density lipoprotein cholesterol levels;	chr11:57249260	chr11:57641212~57641233:+
OV	cis	rs968567	0.528	rs174582	MIMAT0026916	hsa-miR-1908-3p	4.02	7.61e-05	0.34	0.24	Rheumatoid arthritis;Glycerophospholipid levels;Blood metabolite levels;Vitiligo;	chr11:61839696	chr11:61815172~61815192:-
OV	cis	rs12962334	0.518	rs4800141	MIMAT0019871	hsa-miR-4741	4	8.37e-05	0.25	0.24	Breast cancer;	chr18:22984312	chr18:22933407~22933429:+
OV	cis	rs2150052	0.902	rs2418135	MIMAT0030017	hsa-miR-7702	-3.99	8.56e-05	-0.23	-0.24	Neutrophil percentage of white cells;Birth weight;	chr9:111139029	chr9:111271193~111271214:-
OV	cis	rs11082321	1	rs11875806	MIMAT0019871	hsa-miR-4741	-3.98	9.06e-05	-0.34	-0.24	Breast cancer;	chr18:23197450	chr18:22933407~22933429:+
OV	cis	rs7829975	0.871	rs572307	MIMAT0019728	hsa-miR-4660	-3.97	9.11e-05	-0.26	-0.24	Mood instability;	chr8:8721301	chr8:9048453~9048475:+
OV	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-3.97	9.13e-05	-0.18	-0.24	Migraine;	chr10:103273258	chr10:103394341~103394361:-
OV	cis	rs7523273	0.568	rs11118668	MIMAT0004515	hsa-miR-29b-2-5p	3.97	9.28e-05	0.26	0.24	Schizophrenia;	chr1:207844570	chr1:207802492~207802513:-
OV	cis	rs990171	0.52	rs4851605	MIMAT0019927	hsa-miR-4772-3p	-3.95	9.86e-05	-0.23	-0.24	Lymphocyte counts;	chr2:102504409	chr2:102432336~102432357:+
OV	cis	rs990171	0.538	rs4851606	MIMAT0019927	hsa-miR-4772-3p	-3.95	9.86e-05	-0.23	-0.24	Lymphocyte counts;	chr2:102504430	chr2:102432336~102432357:+
OV	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-3.94	0.000104	-0.28	-0.24	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
OV	cis	rs7149242	0.849	rs10146962	MIMAT0000446	hsa-miR-127-3p	3.94	0.000105	0.06	0.24	Platelet count;	chr14:100704203	chr14:100883035~100883056:+
OV	cis	rs7072216	0.77	rs1061115	MIMAT0005878	hsa-miR-1287-5p	3.94	0.000106	0.26	0.24	Metabolite levels;	chr10:98417292	chr10:98395271~98395292:-
OV	cis	rs10256972	0.567	rs2960835	MIMAT0004702	hsa-miR-339-3p	3.92	0.000114	0.26	0.23	Endometriosis;Longevity;	chr7:1163327	chr7:1022955~1022977:-
OV	cis	rs61897795	0.628	rs174579	MIMAT0026916	hsa-miR-1908-3p	3.9	0.00012	0.33	0.23	Neutrophil count;Sum basophil neutrophil counts;	chr11:61838141	chr11:61815172~61815192:-
OV	cis	rs9807989	0.839	rs4988956	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000121	-0.23	-0.23	Asthma;	chr2:102351547	chr2:102432336~102432357:+
OV	cis	rs990171	0.538	rs2075187	MIMAT0019927	hsa-miR-4772-3p	3.9	0.000122	0.23	0.23	Lymphocyte counts;	chr2:102503852	chr2:102432336~102432357:+
OV	cis	rs9807989	0.765	rs13424006	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000122	-0.23	-0.23	Asthma;	chr2:102350776	chr2:102432336~102432357:+
OV	cis	rs9807989	0.801	rs6752482	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000122	-0.23	-0.23	Asthma;	chr2:102351398	chr2:102432336~102432357:+
OV	cis	rs4448343	0.736	rs2297088	MIMAT0000419	hsa-miR-27b-3p	3.9	0.000122	0.22	0.23	Height;	chr9:95480702	chr9:95085505~95085525:+
OV	cis	rs17604090	1	rs17604090	MIMAT0020925	hsa-miR-550a-3-5p	-3.89	0.000125	-0.31	-0.23	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29651822	chr7:29680789~29680808:-
OV	cis	rs4764487	1	rs4764487	MIMAT0000432	hsa-miR-141-3p	-3.89	0.000127	-0.19	-0.23	Mean platelet volume;	chr12:6223672	chr12:6964155~6964176:+
OV	cis	rs11603691	1	rs117981067	MIMAT0004593	hsa-miR-130a-5p	3.88	0.000132	0.39	0.23	Low high density lipoprotein cholesterol levels;	chr11:57296638	chr11:57641212~57641233:+
OV	cis	rs990171	0.687	rs4851616	MIMAT0019927	hsa-miR-4772-3p	-3.88	0.000134	-0.24	-0.23	Lymphocyte counts;	chr2:102535403	chr2:102432336~102432357:+
OV	cis	rs6695223	1	rs4907131	MIMAT0019232	hsa-miR-4423-5p	3.88	0.000134	0.34	0.23	Venous thromboembolism (SNP x SNP interaction);	chr1:85071819	chr1:85133806~85133827:+
OV	cis	rs11603691	1	rs10896598	MIMAT0004593	hsa-miR-130a-5p	3.87	0.000137	0.39	0.23	Low high density lipoprotein cholesterol levels;	chr11:57284533	chr11:57641212~57641233:+
OV	cis	rs990171	0.538	rs4851015	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000138	-0.23	-0.23	Lymphocyte counts;	chr2:102503897	chr2:102432336~102432357:+
OV	cis	rs1974653	0.813	rs9606232	MIMAT0004611	hsa-miR-185-3p	-3.87	0.000138	-0.19	-0.23	Schizophrenia;	chr22:20077847	chr22:20033188~20033209:+
OV	cis	rs9807989	0.839	rs10192036	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.00014	-0.23	-0.23	Asthma;	chr2:102351751	chr2:102432336~102432357:+
OV	cis	rs9807989	0.839	rs10204137	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.00014	-0.23	-0.23	Asthma;	chr2:102351752	chr2:102432336~102432357:+
OV	cis	rs9807989	0.839	rs4988958	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.00014	-0.23	-0.23	Asthma;	chr2:102351825	chr2:102432336~102432357:+
OV	cis	rs9807989	0.839	rs10192157	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.00014	-0.23	-0.23	Asthma;	chr2:102351896	chr2:102432336~102432357:+
OV	cis	rs9807989	0.839	rs10206753	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.00014	-0.23	-0.23	Asthma;	chr2:102351902	chr2:102432336~102432357:+
OV	cis	rs7072216	0.843	rs4400721	MIMAT0005878	hsa-miR-1287-5p	3.86	0.000141	0.27	0.23	Metabolite levels;	chr10:98387340	chr10:98395271~98395292:-
OV	cis	rs11603691	1	rs11602266	MIMAT0004593	hsa-miR-130a-5p	3.86	0.000143	0.37	0.23	Low high density lipoprotein cholesterol levels;	chr11:57327035	chr11:57641212~57641233:+
OV	cis	rs10256972	0.567	rs2949185	MIMAT0004702	hsa-miR-339-3p	3.86	0.000144	0.26	0.23	Endometriosis;Longevity;	chr7:1169377	chr7:1022955~1022977:-
OV	cis	rs10256972	0.552	rs7805591	MIMAT0004702	hsa-miR-339-3p	3.85	0.000146	0.26	0.23	Endometriosis;Longevity;	chr7:1171109	chr7:1022955~1022977:-
OV	cis	rs4851551	0.867	rs2228139	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000149	-0.43	-0.23	Blood protein levels;	chr2:102165189	chr2:102432336~102432357:+
OV	cis	rs990171	0.687	rs4851619	MIMAT0019927	hsa-miR-4772-3p	3.84	0.000153	0.25	0.23	Lymphocyte counts;	chr2:102559952	chr2:102432336~102432357:+
OV	cis	rs9807989	0.811	rs4485584	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000158	-0.23	-0.23	Asthma;	chr2:102354290	chr2:102432336~102432357:+
OV	cis	rs9807989	0.811	rs4485585	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000158	-0.23	-0.23	Asthma;	chr2:102354299	chr2:102432336~102432357:+
OV	cis	rs17036023	1	rs17036023	MIMAT0004985	hsa-miR-942-5p	3.83	0.000158	0.55	0.23	Asthma (childhood onset);	chr1:116587089	chr1:117094655~117094676:+
OV	cis	rs56823429	0.679	rs2966093	MIMAT0030429	hsa-miR-7854-3p	3.83	0.00016	0.27	0.23	HDL cholesterol;	chr16:81505015	chr16:81533942~81533962:+
OV	cis	rs9807989	0.765	rs6751967	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000161	-0.23	-0.23	Asthma;	chr2:102350953	chr2:102432336~102432357:+
OV	cis	rs9807989	0.765	rs6751977	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000161	-0.23	-0.23	Asthma;	chr2:102350970	chr2:102432336~102432357:+
OV	cis	rs9807989	0.765	rs6704565	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000161	-0.23	-0.23	Asthma;	chr2:102350971	chr2:102432336~102432357:+
OV	cis	rs330048	0.545	rs11774353	MIMAT0019728	hsa-miR-4660	3.82	0.000164	0.28	0.23	Systemic lupus erythematosus;	chr8:9295617	chr8:9048453~9048475:+
OV	cis	rs9807989	0.708	rs6543124	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.000166	-0.24	-0.23	Asthma;	chr2:102370999	chr2:102432336~102432357:+
OV	cis	rs12701220	0.948	rs10275712	MIMAT0004702	hsa-miR-339-3p	3.82	0.000167	0.31	0.23	Bronchopulmonary dysplasia;	chr7:1043282	chr7:1022955~1022977:-
OV	cis	rs12701220	0.894	rs2141274	MIMAT0000764	hsa-miR-339-5p	3.82	0.000168	0.22	0.23	Bronchopulmonary dysplasia;	chr7:995081	chr7:1022990~1023012:-
OV	cis	rs11603691	1	rs11228973	MIMAT0004593	hsa-miR-130a-5p	3.81	0.00017	0.36	0.23	Low high density lipoprotein cholesterol levels;	chr11:57262770	chr11:57641212~57641233:+
OV	cis	rs990171	0.538	rs2075193	MIMAT0019927	hsa-miR-4772-3p	3.81	0.000171	0.22	0.23	Lymphocyte counts;	chr2:102501568	chr2:102432336~102432357:+
OV	cis	rs990171	0.538	rs4851017	MIMAT0019927	hsa-miR-4772-3p	-3.81	0.000172	-0.22	-0.23	Lymphocyte counts;	chr2:102504310	chr2:102432336~102432357:+